Letters to Sports: Bill Plaschke is taking the fight to Parkinson's disease
Sandy KaufmanNorth Hollywood
I'm often in the mood to punch him after reading one of Plaschke's columns, but after reading Sunday's column I wanted nothing more than to give him a hug. It reminds me that everyone is fighting a battle none of us can see. Be kind.
Bill HokansSanta Ana
Years of using Bill Plaschke's notoriously incorrect Super Bowl predictions for betting guidance has led me to believe that Bill owes me, as well as his many devoted readers, a significant debt. His brave and inspiring column revealing his ongoing battle with Parkinson's disease repays that debt, and then some.
Rob FleishmanPlacentia
Don't mind admitting I was in tears reading about Bill Plaschke's advancing Parkinson's and the therapy that might slow the 'motion-melting nightmare' down. A 78-year-old former rugby player with arthritis and a bum knee, I'm fortunate in not having to face the dreaded Parky (yet?). If it happens, I know where to go.
Rock on, Bill, and your truly inspiring gym mates. Kudos, also, to staff photographer Robert Gauthier … every picture, indeed, tells a story.
John D.B. GrimshawLake Forest
I too am living with Parkinson's disease. Plaschke's column helped to remind me that I am not alone and this dreaded disease indeed takes no prisoners no matter who you are. I wanted to thank Bill for his column bringing awareness, insight and hope to those of us diagnosed with Parkinson's. Bill's humanitarian columns with a tie-in to the world of sports showcase his best writing. Bill, your observations as a Parkinson's suffer truly hit the mark and deeply resonated with me. I wish you, and all of us afflicted with this condition, the willingness and determination to move forward and to use the power of sport and exercise to combat this devastating disease.
Mike FeixChino Hills
Champion Bill Plaschke goes toe to toe against challenger 'Parky!' Plaschke delivers a vicious uppercut to his opponent. 'Down goes Parky, Down goes Parky!'
Rob ParraRowland Heights
'Calm' is exactly right and what I admire most about Dodgers manager Dave Roberts. Not unlike his most illustrious predecessor, Walter Alston.
Bob WietingSimi Valley
Is the grass really greener if you can't see it? What poetic justice it would be if the Knicks had to end up rehiring Tom Thibodeau and have to give him more money and more authority? If it ain't broke don't fix it.
Russell MorganCarson
It's been a minute since we've seen an outfielder with an arm like Andy Pages. I've taken to calling him the 'Cuban Cannon.' As for Hyeseong Kim, he has been a sparkplug for the offense. I am trying hard to figure out why he doesn't command more playing time.
John TsutsuiHurricane, Utah
Kiké 'The Closer' Hernández. Who needs Shohei Ohtani, Blake Snell or Tyler Glasnow?
Brent MontgomeryLong Beach
The Los Angeles Times welcomes expressions of all views. Letters should be brief and become the property of The Times. They may be edited and republished in any format. Each must include a valid mailing address and telephone number. Pseudonyms will not be used.
Email: sports@latimes.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
8 hours ago
- UPI
Study finds link between metabolic syndrome, Parkinson's disease
Karolinska Institute researchers in Sweden said their study found people with metabolic syndrome have up to a 40% higher risk of developing Parkinson's disease. File Photo by John Angelillo/UPI | License Photo Folks with metabolic syndrome have up to a 40% higher risk of developing Parkinson's disease, a new study says. Metabolic syndrome is a cluster of health problems that include excess belly fat, high blood pressure, elevated blood sugar and abnormal cholesterol levels. It's already known to increase people's risk of heart disease, stroke and type 2 diabetes. And now researchers have found an association between metabolic syndrome and Parkinson's, a degenerative nerve disease that primarily affects motor skills, according to findings published Wednesday in the journal Neurology. "Parkinson's disease is the second most common neurodegenerative disorder among older adults after Alzheimer's disease, and metabolic syndrome affects an estimated 1 in 4 adults and is highly modifiable," researcher Weili Xu, a professor in geriatric epidemiology at the Karolinska Institute in Stockholm, said in a news release. "Our findings suggest that metabolic syndrome may be a modifiable risk factor for Parkinson's disease," Xu said. For the study, researchers analyzed data for more than 467,000 participants in the UK Biobank, a large-scale health research project in the United Kingdom. Nearly 2 of 5 people (38%) had metabolic syndrome. Participants were followed for a median of 15 years, during which more than 3,200 developed Parkinson's disease. Median means half were followed longer, half for a shorter time. People with metabolic syndrome were about 40% more likely to develop Parkinson's than those without the syndrome, results show. Researchers also pooled their research with data gathered in eight previous studies, creating a group of nearly 25 million people with more than 98,500 cases of Parkinson's. In that meta-analysis, the team found a 29% increased risk of Parkinson's among people with metabolic syndrome. "We also found a higher risk of Parkinson's disease for people with both metabolic syndrome and a genetic susceptibility for Parkinson's disease," Xu said. "This suggests that maintaining metabolic health may be especially important for people who have genes that increase their risk for Parkinson's disease." Parkinson's occurs when the body's ability to produce the neurochemical dopamine is damaged or destroyed. A lack of dopamine causes the movement problems associated with the disease. Researchers said the health problems associated with metabolic syndrome might impair dopamine production in the body. High blood pressure and high cholesterol also might damage the tiny blood vessels in the brain, contributing to Parkinson's. Researchers noted that their findings could not prove a direct cause-and-effect link between metabolic syndrome and Parkinson's, only an association. "Future studies are needed to see whether working to control metabolic syndrome could help prevent Parkinson's disease," Xu concluded. More information The American Heart Association has more on metabolic syndrome. Copyright © 2025 HealthDay. All rights reserved.
Business Insider
2 days ago
- Business Insider
Medtronic Stock (MDT) Slides Despite Corporate Re-Jig to Boost Ailing Valuation
Shares in medical technology group Medtronic (MDT) lost ground today after a corporate reshuffle aimed at boosting M&A. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to a report in the Wall Street Journal, activist investor Elliott Investment Management has become one of the group's largest shareholders. This followed a series of so-called friendly talks between the pair focused on boosting the company's valuation – currently $119 billion – and how to concentrate on core assets. The exact size of Elliott's previously undisclosed stake is not known. Veteran Directors It is understood that when Medtronic announces its first quarter results later on Tuesday, August 19, it will reveal that veteran med-tech executives John Groetelaars and Bill Jellison will be joining its board as independent directors. It is also expected to detail the formation of new special committees focused on growth and operations that will include the new directors and be led by Medtronic chief executive Geoff Martha. One of the new committees will look for so-called tuck-in M&A opportunities, research and development investments and potential divestitures. The other will look for ways to boost earnings growth. Undervalued Stock Medtronic develops, manufactures and distributes medical devices and therapies that treat more than 70 health conditions, from Parkinson's to diabetes. The company, which is based in Ireland but has its operational headquarters in Minneapolis, has seen its shares rise more than 16% so far this year. However, the company is still seen as undervalued, especially for being the biggest med-tech company globally by revenue. Medtronic booked more than $32 billion in revenue in 2024. In comparison Boston Scientific (BSX), with a larger market value of almost $153 billion, reported about $17 billion in sales last year. Its share price performance is also trailing. The company has already been making moves to boost its value. It has focused on innovations such as how to treat atrial fibrillation, which has been a huge growth spot in the industry. It is also planning a separation of its diabetes business into a stand-alone group. Is MDT a Good Stock to Buy Now? On TipRanks, MDT has a Moderate Buy consensus based on 13 Buy, 12 Hold and 1 Sell ratings. Its highest price target is $109. MDT stock's consensus price target is $98.44, implying a 6.07% upside. See more MDT analyst ratings
Buzz Feed
5 days ago
- Buzz Feed
Oh Good: Stress Might Cancel Out Your Workout, PT Says
When fitness company Welltech looked at the Google search terms active people were looking up in the UK, they found some seriously frustrated results. Exercise enthusiasts were left wondering why they weren't seeing results from their workouts and why they felt exhausted after a sweaty session, according to their data. But personal trainer David J. Sautter thinks he might have an answer to some of those common frustrations. 'Training isn't just about muscles. It's about your nervous system,' the expert said. 'Pushing through a high-intensity workout when you're emotionally drained can backfire.' How can stress harm your workouts? Sautter shared that, 'Consistent, high stress has been proven to elevate cortisol, which is one of the body's primary fight-or-flight hormones. 'This will disrupt sleep, hinder muscle repair, and blunt your progress. High stress can also lead to performance plateaus, persistent injuries, or even muscle breakdown.' A 2014 paper found that stress affected muscle recovery for a 96-hour period after intense resistance exercise. And the muscle tension associated with chronic stress might make you more prone to strains and sprains, too. Then, there's the mental element to consider. 'If you keep forcing yourself to perform workouts you don't enjoy, then you're setting yourself up to mentally associate exercise with feeling terrible, and you will eventually lose all motivation to work out because your body and brain connect exercise with these negative feelings,' Sautter said. Not exactly a recipe for success in the gym. How can I face less stress during workouts? 'Low-intensity exercise can be extremely beneficial when stress levels are high,' Sautter said. 'This type of activity can boost circulation, stimulate lymphatic drainage, and activate the parasympathetic nervous system. Some great options include zone two cardio, Tai Chi, yoga, swimming, Pilates, dance, or gentle cycling.' And if you're really seeking some low-stress movement, you might want to try zone zero workouts. Lastly, Sautter ended, 'When talking about recovery techniques, I always recommend breathwork. 'Breathwork is free, fast, and incredibly effective in shifting the body out of fight-or-flight mode. Just five minutes of nasal or box breathing (five seconds in, five-second hold, five seconds out, five-second hold) post-workout can accelerate recovery, improve sleep, and calm the mind.'
